XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Revenue:        
Total revenue $ 1,348 $ 998 $ 4,088 $ 26,363
Operating costs and expenses:        
Cost of goods sold $ 85 $ 140 $ 337 $ 21,483
Cost, Product and Service [Extensible List] Product Revenue, Net [Member] Product Revenue, Net [Member] Product Revenue, Net [Member] Product Revenue, Net [Member]
Research and development $ 5,865 $ 32,360 $ 15,040 $ 68,848
Selling, general and administrative 7,057 14,906 15,164 31,622
Restructuring charge 393 0 519 0
Total operating costs and expenses 13,400 47,406 31,060 121,953
Loss from operations (12,052) (46,408) (26,972) (95,590)
Interest and other, net        
Interest expense (2,009) (1,868) (4,265) (3,960)
Interest income and other income (expenses), net 286 900 698 3,135
Total interest and other, net (1,723) (968) (3,567) (825)
Loss from continuing operations before income taxes (13,775) (47,376) (30,539) (96,415)
Benefit from income taxes (92) (281) (90) (274)
Loss from continuing operations (13,683) (47,095) (30,449) (96,141)
Income from discontinued operations, net of tax 6,080 31,551 27,485 47,664
Net loss $ (7,603) $ (15,544) $ (2,964) $ (48,477)
Loss from continuing operations per share - basic $ (3.38) $ (11.79) $ (7.54) $ (24.18)
Loss from continuing operations per share - diluted (3.38) (11.79) (7.54) (24.18)
Income from discontinued operations per share - basic 1.5 7.9 6.81 11.99
Income from discontinued operations per share - diluted 1.5 7.9 6.81 11.99
Net loss per share - basic (1.88) (3.89) (0.73) (12.19)
Net loss per share - diluted $ (1.88) $ (3.89) $ (0.73) $ (12.19)
Weighted average number of common shares used to calculate net income (loss) per share:        
Basic 4,042 3,993 4,040 3,976
Diluted 4,042 3,993 4,040 3,976
Development and Other Revenue [Member]        
Revenue:        
Total revenue $ 133 $ 269 $ 277 $ 1,147
Drug Product Revenue, Net [Member]        
Revenue:        
Total revenue $ 1,215 $ 729 $ 3,811 $ 25,216